title: Compassionate use programs or phase IV trials of innovative molecular targeted drugs in lung cancer: deal or no deal?
authors.forename: Wilfried
authors.initials: W
authors.lastname: Eberhardt
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D017327:Clinical Trials, Phase IV as Topic; D057176:Compassionate Use Trials; D000069347:Erlotinib Hydrochloride; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride